Brazil vs Tajikistan: Cause of death, by non-communicable diseases, male
Brazil
54.0%
in 2021
Tajikistan
51.2%
in 2021
Brazil rank
110th
Tajikistan rank
112th
Cause of death, by non-communicable diseases, male over time
- Brazil
- Tajikistan
How they compare
Brazil currently reports 54.0% against 51.2% in Tajikistan, a difference of 2.8%.
That makes Brazil's figure about 1.1 times Tajikistan's.
Across all 6 years both countries report, Brazil has been ahead every year.
Brazil ranks 110th and Tajikistan ranks 112th of 185 countries.
Brazil has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brazil | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 63.0% | 48.9% | 14.1% | Brazil |
| 2010s | 68.9% | 60.4% | 8.6% | Brazil |
| 2020s | 57.4% | 50.1% | 7.3% | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, Brazil or Tajikistan?
- Brazil, at 54.0% against 51.2% in Tajikistan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between Brazil and Tajikistan?
- 2.8%, with Brazil ahead.
- How many years of comparable data are there for Brazil and Tajikistan?
- 6 years are reported by both, from 2000 to 2021.
- How do Brazil and Tajikistan rank globally for cause of death, by non-communicable diseases, male?
- Brazil ranks 110th and Tajikistan ranks 112th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.